Literature DB >> 3878501

Microbiology of recently treated acute otitis media compared with previously untreated acute otitis media.

C J Harrison, M I Marks, D F Welch.   

Abstract

Isolates were obtained from 169 middle ear aspirates of 148 children with recently treated acute otitis media (RTOM) and from 123 aspirates of 84 children with previously untreated acute otitis media (UOM). In RTOM Streptococcus pneumoniae and Group A streptococcus (P less than 0.02) were recovered less frequently whereas Staphylococcus aureus (P less than 0.001) and Haemophilus influenzae (P less than 0.02) were recovered more frequently than in UOM. Patients with RTOM had more beta-lactamase-producing organisms and multiple isolates. Bilateral sterile aspirates were more common in RTOM although bilateral otitis media was more common in UOM. In RTOM most Branhamella catarrhalis isolates were co-pathogens whereas Staphylococcus epidermidis were always isolated in pure culture. Amoxicillin was the antimicrobial most frequently (83.9%) received for the recently treated episode of otitis media. In RTOM 62.4% of isolates were susceptible to previously prescribed antibiotics, suggesting that factors other than antimicrobial susceptibility are also important in the occurrence of RTOM.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3878501     DOI: 10.1097/00006454-198511000-00009

Source DB:  PubMed          Journal:  Pediatr Infect Dis        ISSN: 0277-9730


  10 in total

1.  The use of tympanocentesis in the diagnosis and management of acute otitis media.

Authors:  Michael E Pichichero; Tracy Wright
Journal:  Curr Infect Dis Rep       Date:  2006-05       Impact factor: 3.725

2.  Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin.

Authors:  F Scaglione; G Demartini; S Dugnani; M M Arcidiacono; J P Pintucci; F Fraschini
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

3.  Serum antibody response to three non-typeable Haemophilus influenzae outer membrane proteins during acute otitis media and nasopharyngeal colonization in otitis prone and non-otitis prone children.

Authors:  Ravinder Kaur; Janet R Casey; Michael E Pichichero
Journal:  Vaccine       Date:  2010-12-01       Impact factor: 3.641

Review 4.  Advances in pneumococcal vaccines: advantages for infants and children.

Authors:  Jolanta Bernatoniene; Adam Finn
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Measurement of cefaclor and amoxicillin-clavulanic acid levels in middle-ear fluid in patients with acute otitis media.

Authors:  F Scaglione; D Caronzolo; J P Pintucci; F Fraschini
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

6.  Release of leukotriene B4 from human neutrophils after interaction with nontypeable Haemophilus influenzae.

Authors:  R Garofalo; H Faden; S Sharma; P L Ogra
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

7.  Relationship with original pathogen in recurrence of acute otitis media after completion of amoxicillin/clavulanate: bacterial relapse or new pathogen.

Authors:  Ravinder Kaur; Janet R Casey; Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

8.  Pharmacological treatment of acute otitis media in children. A comparison among seven locations: Tenerife, Barcelona and Valencia (Spain), Toulouse (France), Smolensk (Russia), Bratislava (Slovakia) and Sofia (Bulgaria).

Authors:  E Sanz; M A Hernández; M Kumari; S Ratchina; L Stratchounsky; M A Peiré; M Lapeyre-Mestre; B Horen; M Kriska; H Krajnakova; H Momcheva; D Encheva; I Martínez-Mir; V Palop
Journal:  Eur J Clin Pharmacol       Date:  2004-01-29       Impact factor: 2.953

9.  Pharmacokinetics and efficacy of linezolid in a gerbil model of Streptococcus pneumoniae-induced acute otitis media.

Authors:  William R Humphrey; Mark H Shattuck; Raymond J Zielinski; Ming-Shang T Kuo; John J Biermacher; Donald P Smith; Jana L Jensen; Ronda D Schaadt; Gary E Zurenko; Ivan M Richards
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

10.  Daycaritis.

Authors:  Pamela Bailey
Journal:  Clin Pediatr Emerg Med       Date:  2013-06-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.